Apolipoprotein E genotype: Epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease

Journal of the American College of Cardiology

Volumn 35, Issue 5, 2000, Pages 1192-1199

  Frikke Schmidt, Ruth ^a   Tybjærg Hansen, Anne ^a,b   Steffensen, Rolf ^c   Jensen, Gorm ^b   Nordestgaard, Børge G ^b,d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c University of Copenhagen   (Denmark)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LIPID; LIPOPROTEIN;

ADULT; AGE; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DENMARK; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENOTYPE; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; DENMARK; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POLYMORPHISM, GENETIC; RISK FACTORS; SEX CHARACTERISTICS; SEX DISTRIBUTION;

EID: 0034127395     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00520-9     Document Type: Article

References (33)

1. Mahley RW, Rall SC. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York: McGraw-Hill, 1995, pp. 1953-80.
2. Paik Y.K., Chang D.J., Reardon C.A., et al. Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci USA. 82:1985;3445-3449.
3. Das H.K., McPherson J., Bruns G.A., et al. Isolation, characterization and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem. 260:1985;6240-6247.
4. Reilly S.L., Ferrell R.E., Kottke B.A., et al. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, Minnesota. I. Pleiotropic effects on means and variances. Am J Hum Genet. 49:1991;1155-1166.
5. Reilly S.L., Ferrell R.E., Kottke B.A., Sing C.F. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants. Am J Hum Genet. 51:1992;1311-1324.
6. Reilly S.L., Ferrell R.E., Sing C.F. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. III. Correlations and covariances. Am J Hum Genet. 55:1994;1001-1018.
7. Xhignesse M., Lussier-Cacan S., Sing C.F., et al. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb. 11:1991;1100-1110.
8. Kaprio J., Ferrell R.E., Kottke B.A., et al. Effects of polymorphisms in apolipoproteins E, A-IV and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb. 11:1991;1330-1348.
9. de Knijff P., Havekes L.M. Apolipoprotein E as a risk factor for coronary heart disease a genetic and molecular biology approach . Curr Opin Lipidol. 7:1996;59-63.
10. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
11. Stengard J.H., Pekkanen J., Ehnholm C., et al. Genotypes with the apolipoprotein ε4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men. Hum Genet. 97:1996;677-684.
12. Tiret L., de Knijff P., Menzel H.J., et al. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. Arterioscler Thromb. 14:1994;1617-1624.
13. Wittrup H.H., Tybjærg-Hansen A., Abildgaard S., et al. A common substitution (asn291ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J Clin Invest. 99:1997;1606-1613.
14. Agerholm-Larsen B., Nordestgaard B.G., Steffensen R., et al. ACE gene polymorphism ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study . Circulation. 95:1997;2358-2367.
15. 455→A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. J Clin Invest. 99:1997;3034-3039.
16. Appleyard M., Hansen A.T., Jensen G., et al. The Copenhagen City Heart Study. Østerbroundersøgelsen. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-83). The Copenhagen City Heart Study Group. Scand J Soc Med Suppl. 41:1989;1-160.
17. Nordestgaard B.G., Abildgaard S., Wittrup H.H., et al. Heterozygous lipoprotein lipase deficiency. Frequency in the general population, effect on plasma lipid levels and risk of ischemic heart disease. Circulation. 96:1997;1737-1744.
18. Tybjærg-Hansen A., Steffensen R., Meinertz H., et al. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. N Engl J Med. 338:1998;1577-1584.
19. Nordestgaard B.G., Agerholm-Larsen B., Wittrup H.H., Tybjærg-Hansen A. A prospective cardiovascular population study used in genetic epidemiology. The Copenhagen City Heart Study. Scand J Clin Lab Invest. 56:1996;65-71.
20. Management of stable angina pectoris recommendations of the Task Force of the European Society of Cardiology . Eur Heart J. 18:1997;394-413.
21. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 31:1990;545-548.
22. SPSS for Windows. Base system user's guide and professional statistics, release 7.5. Chicago, IL. SPSS, Inc., 1997.
23. Hosmer D.W., Lemeshow S. Applied Logistic Regression. 1989;John Wiley & Sons, Inc, New York.
24. Menard S. Applied Logistic Regression Analysis. 1995;Sage Publications, London.
25. Hennekens CH, Buring JE. Measures of disease frequency and association. In: Mayrent SL, editor. Epidemiology in Medicine. 1st ed. Boston/Toronto: Little, Brown and Company, 1987, pp. 54-98.
26. Luc G., Bard J.-M., Arveiler D., et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb. 14:1994;1412-1419.
27. Wilson P.W.F., Schaefer E.J., Larson M.G., Ordovas J.M. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol. 16:1996;1250-1255.
28. Nordestgaard B.G., Nielsen L.B. Atherosclerosis and arterial influx of lipoproteins. Curr Opin Lipidol. 5:1994;252-257.
29. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level a meta-analysis of population-based prospective studies . J Cardiovasc Risk. 3:1996;213-219.
30. Sing C.F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 37:1985;268-285.
31. Utermann G., Albrecht G., Steinmetz A. Polymorphism of apolipoprotein E. I. Methodological aspects and diagnosis of hyperlipoproteinemia type III without ultracentrifugation. Clin Genet. 14:1978;351-358.
32. Utermann G., Vogelberg K.H., Steinmetz A., et al. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet. 15:1979;37-62.
33. Utermann G., Pruin N., Steinmetz A. Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet. 15:1979;63-72.